NorPept
Se alle peptider
fatLoss

Semamax

Semaglutide

Semaglutide is a long-acting GLP-1 receptor agonist originally developed for the treatment of type 2 diabetes. It mimics the action of human GLP-1 to regulate blood sugar, insulin secretion, and appetite. Semaglutide has gained widespread use for weight management.

Molekylære data

99.3%

Renhet

4113.58 g/mol

Molekylvekt

SEM-2026-0267

Batchnummer

HPLC + Mass Spectrometry

Testmetode

Verifisert ren

Labtestet

Aminosyresekvens

Modified GLP-1(7-37) analog with C-18 fatty acid chain

Forskningsstudier

Insulin secretion and blood glucose regulation
Appetite and food intake reduction
Weight management in obese and overweight patients
Cardiometabolic marker improvement
Cardiovascular risk reduction in diabetics

Labverifisering

Skann for å verifisere

Batchnummer: SEM-2026-0267

Renhet: 99.3%

Effektprofil

Recovery
1
Energy
2
Anti-Aging
2
Muscle
1
Fat Loss
5
Skin
1
Sleep
1
Cognitive
1
Ekspertvurdering
4.5

Viktigste fordeler

Enhances insulin secretion and lowers blood glucose
Significantly reduces appetite and food intake
Proven weight loss effects in obese and overweight patients
Improves cardiometabolic markers (HbA1c, LDL, blood pressure)
Reduces risk of major cardiovascular events in diabetics
Once-weekly dosing with sustained effect

Passer godt med

Disse peptidene kombineres ofte med Semamax for bedre resultater.

Klar til å utforske Semamax?

Ta vår guidede quiz for å finne peptider tilpasset dine forskningsmål, eller bla gjennom hele katalogen.